Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening
NCT ID: NCT01971736
Last Updated: 2013-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2012-09-30
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1064nm laser, laxity
split-face single-blind randomized placebo-controlled trial evaluating improvement in facial skin laxity of the side of the face with placebo versus laser
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Patients on immunosuppression
3. Patients with other known internal malignancy
4. Patients with malnutrition, vitamin or mineral insufficiency
5. Patients on colchicine, penicillamine
6. Patients with weight loss 7.5% of usual body weight within 3 months
7. history of botulinum toxin injection within 6 months
8. history of facial filler injection within 1year
35 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Phramongkutklao College of Medicine and Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pinyapat - Kanechorn-Na-Ayuthaya, M.D.
Role: PRINCIPAL_INVESTIGATOR
Phramongkutklao College of Medicine and Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of dermatology, Phramongkutklao hospital
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R079h/55
Identifier Type: -
Identifier Source: org_study_id